Med. praxi. 2025;22(3):E1-E4 | DOI: 10.36290/med.2025.029

Tobacco/nicotine addiction in daily practice

prof. MUDr. Eva Králíková, CSc.1,2, MUDr. Zuzana Adamčeková1
1 Centrum pro závislé na tabáku III. interní kliniky – kliniky endokrinologie a metabolismu 1. LF UK a VFN v Praze
2 Ústav hygieny a epidemiologie 1. LF UK a VFN v Praze

In many practices, interest in the diagnosis of F17 ends with an inquiry about smoking or a recommendation to stop. However, this is a disease for which effective treatments exist and should therefore be offered and available in the same way as treatments for other diseases. For example, there are roughly twice as many smokers (1) as diabetics in the Czech Republic, but the treatment options offered do not match this. In addition, other forms of tobacco or nicotine than cigarettes are now available. As a standard, we should ask about the use of all forms of tobacco or smoking, recommend abstinence, inform about treatment, and offer it where appropriate. Simply recommending ‚Don‘t smoke‘ is not enough; for comparison, think of a diabetic to whom we would simply say ‚Don‘t eat sweets‘. In practice, there is usually only time for a short intervention, but even this is very important – every patient should hear it from every doctor. That is its effectiveness. The article provides an estimate of the health risks of each product, the risk of addiction, and current treatment options for F17.

Keywords: smoking, tobacco, nicotine, practice, treatment

Received: July 31, 2024; Revised: April 1, 2025; Accepted: April 17, 2025; Published: June 26, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíková E, Adamčeková Z. Tobacco/nicotine addiction in daily practice. Med. praxi. 2025;22(3):E1-4. doi: 10.36290/med.2025.029.
Download citation
PDF will be unlocked 26.6.2026

References

  1. Csémy L, Dvořáková Z, Fialová A, et al. Národní výzkum užívání tabáku a alkoholu v České republice 2023 (NAUTA). SZÚ; 2024. https://szu.cz/wp­‑content/uploads/2024/05/Narodni­‑vyzkum­‑uzivani­‑tabaku­‑a-alkoholu­‑v-Ceske­‑republice-2023.pdf.
  2. Yoong SL, Tursan d'Espaignet E, Wiggers J, et al. Tobacco and postsurgical outcomes: WHO tobacco knowledge summaries. Geneva: World Health Organization; 2020. Licence: CC BY­‑NC­‑SA 3.0 IGO.https://iris.who.int/bitstream/handle/10665/330485/9789240000360-eng.pdf.
  3. Lucas C, Martin WJ. Smoking and drug interactions. Aust Prescr. 2013;36:102-4. https://doi.org/10.18773/austprescr.2013.037. Go to original source...
  4. WHO clinical treatment guideline for tobacco cessation in adults. Geneva: World Health Organization; 2024. Licence: CC BY­‑NC­‑SA 3.0 IGO. https://iris.who.int/bitstream/handle/10665/377825/9789240096431-eng.pdf?sequence=4.
  5. Králíková E, Aschermann M, Dvořák V, et al. Léčba závislosti na tabáku. Klinický doporučený postup. UZIS, 2022. https://kdp.uzis.cz/index.php?pg=kdp&id=56.
  6. Keeney E, Welton NJ, Stevenson M, et al. Cost­‑Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events. Value Health. 2021 Jun;24(6):780-788. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177405/. Go to original source... Go to PubMed...
  7. US FDA. Health Effects of Tobacco Use. https://www.fda.gov/tobacco­‑products/public­‑health­‑education/health­‑effects­‑tobacco­‑use.
  8. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine­‑containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218-25. https://pubmed.ncbi.nlm.nih.gov/24714502/. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.